Overcoming Key Operational Challenges in Integrating Bispecific Therapies

Experts discuss the most common logistical challenges encountered when implementing bispecific therapies as well as the primary barriers smaller community practices face in operationalizing bispecific antibody treatments.

EP: 1.Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology

EP: 2.Revolutionizing Cancer Treatment: Key Bispecific Antibody Approvals

EP: 3.How Bispecific Antibodies Are Reshaping Cancer Care

EP: 4.Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access

EP: 5.Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations

Now Viewing

EP: 6.Overcoming Key Operational Challenges in Integrating Bispecific Therapies

Video content above is prompted by the following:

1. What are the most common logistical challenges you encounter when implementing bispecific therapies?
2. What are the primary barriers that smaller community practices face in operationalizing bispecific antibody treatments?

Related Videos

Related Content

Advertisement

March 20th 2025

Hemoglobin May Protect Against Inflammation From Rheumatoid Arthritis

Brooke McCormick

Regulating hemoglobin levels could help reduce inflammation and improve rheumatoid arthritis management.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

March 19th 2025

STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children

Christina Mattina

Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

March 18th 2025

Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic

Christina Mattina

The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.

March 18th 2025

MRI Could Aid in Early Differential Diagnosis of DMD, BMD

Rose McNulty

Multiparametric quantitative MRI could potentially help differentiate between Duchenne muscular dystrophy and Becker muscular dystrophy early and improve the management of these conditions.

Related Content

Advertisement

March 20th 2025

Hemoglobin May Protect Against Inflammation From Rheumatoid Arthritis

Brooke McCormick

Regulating hemoglobin levels could help reduce inflammation and improve rheumatoid arthritis management.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

March 19th 2025

STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children

Christina Mattina

Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

March 18th 2025

Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic

Christina Mattina

The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.

March 18th 2025

MRI Could Aid in Early Differential Diagnosis of DMD, BMD

Rose McNulty

Multiparametric quantitative MRI could potentially help differentiate between Duchenne muscular dystrophy and Becker muscular dystrophy early and improve the management of these conditions.